3D conformal MRI-guided transurethral ultrasound therapy: Results of gel phantom experiments

W. A. N'Djin, M. Burtnyk, S. McCormick, M. Bronskill, R. Chopra

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

MRI-guided transurethral ultrasound therapy shows promise for minimally invasive treatment of localized prostate cancer. Previous in-vivo studies demonstrated the feasibility of performing conservative treatments using real-time temperature feedback to control accurately the establishment of coagulative lesions within circumscribed prostate regions. This in-vitro study tested device configuration and control options for achieving full prostate treatments. A multi-channel MRI compatible ultrasound therapy system was evaluated in gel phantoms using 3 canine prostate models. Prostate profiles were 5mm-step-segmented from T2-weighted MR images performed during previous in-vivo experiments. During ultrasound exposures, each ultrasound element was controlled independently by the 3D controller. Decisions on acoustic power, frequency, and device rotation rate were made in real time based on MR thermometry feedback and prostate radii. Low and high power treatment approaches using maximum acoustic powers of 10 or 20 W.cm-2 were tested as well as single and dual-frequency strategies (4.05/13.10 MHz). The dual-frequency strategy used either the fundamental frequency or the 3rd harmonic component, depending on the prostate radius. The 20 W.cm-2 dual frequency approach was the most efficient configuration in achieving full prostate treatments. Treatment times were about half the duration of those performed with 10 W.cm-2 configurations. Full prostate coagulations were performed in 16.3 ± 6.1 min at a rate of 1.8 ± 0.2 cm3.min-1, and resulted in very little undertreated tissue (< 3%). Surrounding organs positioned beyond a safety distance of 1.4 ± 1.0 mm from prostate boundaries were not damaged, particularly rectal wall tissues. In this study, a 3D, MR-thermometry-guided transurethral ultrasound therapy was validated in vitro in a tissue-mimicking phantom for performing full prostate treatment. A dualfrequency configuration with 20 W.cm-2 ultrasound intensity exposure showed good results with direct application to full human prostate treatments.

Original languageEnglish (US)
Title of host publicationAIP Conference Proceedings
Pages132-137
Number of pages6
Volume1359
DOIs
StatePublished - 2011
Event10th International Symposium on Therapeutic Ultrasound, ISTU 2010 - Tokyo, Japan
Duration: Jun 9 2010Jun 12 2010

Other

Other10th International Symposium on Therapeutic Ultrasound, ISTU 2010
CountryJapan
CityTokyo
Period6/9/106/12/10

Fingerprint

therapy
gels
configurations
temperature measurement
radii
acoustics
coagulation
organs
lesions
safety
controllers
cancer
harmonics
profiles

Keywords

  • 3D temperature feedback controller
  • Cancer
  • Canine prostate
  • Mini-invasive
  • Thermal therapy
  • Transurethral
  • Ultrasound

ASJC Scopus subject areas

  • Physics and Astronomy(all)

Cite this

N'Djin, W. A., Burtnyk, M., McCormick, S., Bronskill, M., & Chopra, R. (2011). 3D conformal MRI-guided transurethral ultrasound therapy: Results of gel phantom experiments. In AIP Conference Proceedings (Vol. 1359, pp. 132-137) https://doi.org/10.1063/1.3607894

3D conformal MRI-guided transurethral ultrasound therapy : Results of gel phantom experiments. / N'Djin, W. A.; Burtnyk, M.; McCormick, S.; Bronskill, M.; Chopra, R.

AIP Conference Proceedings. Vol. 1359 2011. p. 132-137.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

N'Djin, WA, Burtnyk, M, McCormick, S, Bronskill, M & Chopra, R 2011, 3D conformal MRI-guided transurethral ultrasound therapy: Results of gel phantom experiments. in AIP Conference Proceedings. vol. 1359, pp. 132-137, 10th International Symposium on Therapeutic Ultrasound, ISTU 2010, Tokyo, Japan, 6/9/10. https://doi.org/10.1063/1.3607894
N'Djin WA, Burtnyk M, McCormick S, Bronskill M, Chopra R. 3D conformal MRI-guided transurethral ultrasound therapy: Results of gel phantom experiments. In AIP Conference Proceedings. Vol. 1359. 2011. p. 132-137 https://doi.org/10.1063/1.3607894
N'Djin, W. A. ; Burtnyk, M. ; McCormick, S. ; Bronskill, M. ; Chopra, R. / 3D conformal MRI-guided transurethral ultrasound therapy : Results of gel phantom experiments. AIP Conference Proceedings. Vol. 1359 2011. pp. 132-137
@inproceedings{3c81b22937724952afeaae6872ce26a9,
title = "3D conformal MRI-guided transurethral ultrasound therapy: Results of gel phantom experiments",
abstract = "MRI-guided transurethral ultrasound therapy shows promise for minimally invasive treatment of localized prostate cancer. Previous in-vivo studies demonstrated the feasibility of performing conservative treatments using real-time temperature feedback to control accurately the establishment of coagulative lesions within circumscribed prostate regions. This in-vitro study tested device configuration and control options for achieving full prostate treatments. A multi-channel MRI compatible ultrasound therapy system was evaluated in gel phantoms using 3 canine prostate models. Prostate profiles were 5mm-step-segmented from T2-weighted MR images performed during previous in-vivo experiments. During ultrasound exposures, each ultrasound element was controlled independently by the 3D controller. Decisions on acoustic power, frequency, and device rotation rate were made in real time based on MR thermometry feedback and prostate radii. Low and high power treatment approaches using maximum acoustic powers of 10 or 20 W.cm-2 were tested as well as single and dual-frequency strategies (4.05/13.10 MHz). The dual-frequency strategy used either the fundamental frequency or the 3rd harmonic component, depending on the prostate radius. The 20 W.cm-2 dual frequency approach was the most efficient configuration in achieving full prostate treatments. Treatment times were about half the duration of those performed with 10 W.cm-2 configurations. Full prostate coagulations were performed in 16.3 ± 6.1 min at a rate of 1.8 ± 0.2 cm3.min-1, and resulted in very little undertreated tissue (< 3{\%}). Surrounding organs positioned beyond a safety distance of 1.4 ± 1.0 mm from prostate boundaries were not damaged, particularly rectal wall tissues. In this study, a 3D, MR-thermometry-guided transurethral ultrasound therapy was validated in vitro in a tissue-mimicking phantom for performing full prostate treatment. A dualfrequency configuration with 20 W.cm-2 ultrasound intensity exposure showed good results with direct application to full human prostate treatments.",
keywords = "3D temperature feedback controller, Cancer, Canine prostate, Mini-invasive, Thermal therapy, Transurethral, Ultrasound",
author = "N'Djin, {W. A.} and M. Burtnyk and S. McCormick and M. Bronskill and R. Chopra",
year = "2011",
doi = "10.1063/1.3607894",
language = "English (US)",
isbn = "9780735409170",
volume = "1359",
pages = "132--137",
booktitle = "AIP Conference Proceedings",

}

TY - GEN

T1 - 3D conformal MRI-guided transurethral ultrasound therapy

T2 - Results of gel phantom experiments

AU - N'Djin, W. A.

AU - Burtnyk, M.

AU - McCormick, S.

AU - Bronskill, M.

AU - Chopra, R.

PY - 2011

Y1 - 2011

N2 - MRI-guided transurethral ultrasound therapy shows promise for minimally invasive treatment of localized prostate cancer. Previous in-vivo studies demonstrated the feasibility of performing conservative treatments using real-time temperature feedback to control accurately the establishment of coagulative lesions within circumscribed prostate regions. This in-vitro study tested device configuration and control options for achieving full prostate treatments. A multi-channel MRI compatible ultrasound therapy system was evaluated in gel phantoms using 3 canine prostate models. Prostate profiles were 5mm-step-segmented from T2-weighted MR images performed during previous in-vivo experiments. During ultrasound exposures, each ultrasound element was controlled independently by the 3D controller. Decisions on acoustic power, frequency, and device rotation rate were made in real time based on MR thermometry feedback and prostate radii. Low and high power treatment approaches using maximum acoustic powers of 10 or 20 W.cm-2 were tested as well as single and dual-frequency strategies (4.05/13.10 MHz). The dual-frequency strategy used either the fundamental frequency or the 3rd harmonic component, depending on the prostate radius. The 20 W.cm-2 dual frequency approach was the most efficient configuration in achieving full prostate treatments. Treatment times were about half the duration of those performed with 10 W.cm-2 configurations. Full prostate coagulations were performed in 16.3 ± 6.1 min at a rate of 1.8 ± 0.2 cm3.min-1, and resulted in very little undertreated tissue (< 3%). Surrounding organs positioned beyond a safety distance of 1.4 ± 1.0 mm from prostate boundaries were not damaged, particularly rectal wall tissues. In this study, a 3D, MR-thermometry-guided transurethral ultrasound therapy was validated in vitro in a tissue-mimicking phantom for performing full prostate treatment. A dualfrequency configuration with 20 W.cm-2 ultrasound intensity exposure showed good results with direct application to full human prostate treatments.

AB - MRI-guided transurethral ultrasound therapy shows promise for minimally invasive treatment of localized prostate cancer. Previous in-vivo studies demonstrated the feasibility of performing conservative treatments using real-time temperature feedback to control accurately the establishment of coagulative lesions within circumscribed prostate regions. This in-vitro study tested device configuration and control options for achieving full prostate treatments. A multi-channel MRI compatible ultrasound therapy system was evaluated in gel phantoms using 3 canine prostate models. Prostate profiles were 5mm-step-segmented from T2-weighted MR images performed during previous in-vivo experiments. During ultrasound exposures, each ultrasound element was controlled independently by the 3D controller. Decisions on acoustic power, frequency, and device rotation rate were made in real time based on MR thermometry feedback and prostate radii. Low and high power treatment approaches using maximum acoustic powers of 10 or 20 W.cm-2 were tested as well as single and dual-frequency strategies (4.05/13.10 MHz). The dual-frequency strategy used either the fundamental frequency or the 3rd harmonic component, depending on the prostate radius. The 20 W.cm-2 dual frequency approach was the most efficient configuration in achieving full prostate treatments. Treatment times were about half the duration of those performed with 10 W.cm-2 configurations. Full prostate coagulations were performed in 16.3 ± 6.1 min at a rate of 1.8 ± 0.2 cm3.min-1, and resulted in very little undertreated tissue (< 3%). Surrounding organs positioned beyond a safety distance of 1.4 ± 1.0 mm from prostate boundaries were not damaged, particularly rectal wall tissues. In this study, a 3D, MR-thermometry-guided transurethral ultrasound therapy was validated in vitro in a tissue-mimicking phantom for performing full prostate treatment. A dualfrequency configuration with 20 W.cm-2 ultrasound intensity exposure showed good results with direct application to full human prostate treatments.

KW - 3D temperature feedback controller

KW - Cancer

KW - Canine prostate

KW - Mini-invasive

KW - Thermal therapy

KW - Transurethral

KW - Ultrasound

UR - http://www.scopus.com/inward/record.url?scp=80053648648&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053648648&partnerID=8YFLogxK

U2 - 10.1063/1.3607894

DO - 10.1063/1.3607894

M3 - Conference contribution

AN - SCOPUS:80053648648

SN - 9780735409170

VL - 1359

SP - 132

EP - 137

BT - AIP Conference Proceedings

ER -